The prediction of coronary artery disease based on non-invasive examinations and heme oxygenase 1 polymorphism versus virtual histology

Journal of Invasive Cardiology

Volumn 25, Issue 1, 2013, Pages 32-37

  Kovarnik, Tomas ^a   Kral, Ales ^a   Skalicka, Hana ^a   Mintz, Gary S ^b   Kralik, Lubomir ^a   Chval, Martin ^c   Horak, Jan ^a   Skalicka, Lenka ^a   Sonka, Milan ^d   Wahle, Andreas ^d   Downe, Richard W ^d   Uhrova, Jana ^a   Benakova, Hana ^a   Cernohousova, Lenka ^a   Martasek, Pavel ^a   Belohlavek, Jan ^a   Aschermann, Michael ^a   Linhart, Ales ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^c CHARLES UNIVERSITY   (Czech Republic)

^d IA United States   (United States)

Author keywords

inflammation; plaque composition

Indexed keywords

APOLIPOPROTEIN A; C REACTIVE PROTEIN; CD40 ANTIGEN; CHOLESTEROL; HEME OXYGENASE 1; HIGH SENSITIVITY C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; ANGIOCARDIOGRAPHY; ARTERIAL WALL THICKNESS; ARTICLE; CALCIFICATION; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; FEMALE; FRAMINGHAM RISK SCORE; GENETIC ANALYSIS; GENETIC RISK; HEART INFARCTION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INTERMETHOD COMPARISON; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; SMOKING; SYSTOLIC BLOOD PRESSURE; VIRTUAL HISTOLOGY INTRAVASCULAR ULTRASOUND;

AGED; ANGINA, STABLE; APOLIPOPROTEINS A; BIOLOGICAL MARKERS; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CORONARY ARTERY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEME OXYGENASE-1; HUMANS; MALE; MIDDLE AGED; PHYSICAL EXAMINATION; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 84872350995     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Nguyen-Thanh HT, Benzaquen BS. Screening for subclinical coronary artery disease measuring carotid intima media thickness. Am J Cardiol. 2009;104(10):1383-1388.
2. van Wijk D F, Boekholdt SM. Improving risk stratifcation for cardiovascular disease. Expert Rev Cardiovasc Ther. 2010;8(8):1091-1109.
3. Kral A, Kovarnik T, Kralik L, et al. Genetic variants in haem oxygenase-1 and en-dothelial nitric oxide synthase infuence the extent and evolution of coronary artery atherosclerosis. Folia Biologica (Praha). 2011;57(5):182-190.
4. Taha H, Skrzypek K, Guevara I, et al. Role of heme oxygenase-1 in human endo-thelial cells: lesson from the promoter allelic variants. Arterioscler Thromb Vasc Biol. 2010;30(8):1634-1641.
5. Hayashi S, Omata Y, Sakamoto H, Hara T, Sagara Y, Noguchi M. Characterization of rat heme oxygenase-3 gene. Implication of processed pseudogenes derived from heme oxygenase-2 gene. Gene. 2004;336(2):241-250.
6. Peterson SJ, Frishman WH. Targeting heme oxygenase. Therapeutic implications for diseases of the cardiovascular system. Cardiol Rev. 2009;17(3):99-111.
7. Kaneda H, Ohno M, Taguchi J, et al. Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler Thromb Vasc Biol. 2002;22(10):1680- 1685.
8. Morita T. Heme oxygenase and atherosclerosis. Artherioscler Thromb Vasc Biol. 2005;25(9):1786-1795.
9. Virmani R, Burke A P, Kolodgie FD, Farb A. Pathology of thin-cap fbroatheroma: a type of vulnerable plaque. J Interv Cardiol. 2003;16(3):267-272.
10. Stone G W, Maehara A, Lansky A, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364(3):226-235.
11. Wilson P, D́Agostino R, Levy D, Belanger A, Silbershatz H, Kannel W. Prediction of coronary heart disease using risk factors categories. Circulation. 1998;97(18):1837-1847.
12. Nambi V, Chambless L, Folsom AR, et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol. 2010;55(15):1600-1607.
13. García-García HM, Mintz GS, Lerman A, et al. Tissue characterisation using in-travascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting. Eurointervention. 2009;5(2):177-189.
14. Wald DS, Bestwick J P, Morton G, et al. Combining carotid intima-media thickness with carotid plaque on screening for coronary heart disease. J Med Screen. 2009;16(3):155-159.
15. Abraham NG, Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev. 2008;60(1):79-127.
16. Lin Y, Berg AH, Iyengar P, et al. The hyperglycemia-induced infammatory response in adipocytes: the role of reactive oxygen species. J Biol Chem. 2005;280(6):4617-4626
17. Ndisang J F, Lane N, Syed N, Jadhav A. Up-regulating the heme oxygenase system with hemin improves insulin sensitivity and glucose metabolism in adult spontaneously hypertensive rats. Endocrinology. 2010;151(2):549-560.
18. Ndisang J F, Jadhav A. Heme oxygenase system enhances insulin sensitivity and glucose metabolism in streptozotocin-induced diabetes. Am J Physiol Endocrinol Metab. 2009;296(4):E829-E841.
19. Oda E, Kawai R. Bilirubin is negatively associated with hemoglobin A1c independently of other cardiovascular risk factors in apparently healthy Japanese men and women. Circ J. 2011;75(1):190-195.
20. Liu X, Wei J, Peng DH, Layne MD, Yet S F. Absence of heme oxygenase-1 exacerbates myocardial ischemia/reperfusion injury in diabetic mice. Diabetes. 2005;54(3):778-784.
21. Hangaishi M, Ishizaka N, Aizawa T, et al. Induction of heme oxygenase-1 can act protectively against cardiac ischemia/reperfusion in vivo. Biochem Biophys Res Commun. 2000;279(2):582-588.
22. Abraham NG, Kappas A. Heme oxygenase and the cardiovascular and renal system. Free Radic Biol Med. 2005;39(1):1-25.
23. Beltowski J, Jamroz A, Borkowska E. Heme oxygenase and carbon monoxide in the physiology and pathology of the cardiovascular system. Postepy Hig Med Dosw (Online). 2004;58:83-99.
24. Ushiyama M, Morita T, Katayama S. Carbon monoxide regulates blood pressure cooperatively with nitric oxide in hypertensive rats. Heart Vessels. 2002;16(5):189-195.
25. Bluestein D, Alemu Y, Avrahami I, et al. Infuence of microcalcifcations on vulnerable plaque mechanics using FSI modeling. J Biomech. 2008;41(5):1111-1118.
26. Li YG, Wang DM, Chen SM, et al. Heme oxygenase-1 expression and coronary heart disease - association between levels of heme oxygenase-1 expression and angiographic morphology as well as the quantity of coronary lesions. Acta Cardiol. 2006;61(3):295-300.
27. Idriss NK, Blann AD, Lip G. Hemoxygenase-1 in cardiovascular disease. J Am Coll Cardiol. 2008;52(12):971-978.
28. Kawamura K, Ishikawa K, Wada Y, et al. Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction. Arterioscler Thromb Vasc Biol. 2005;25(1):155-160.
29. Otterbein LE, Kolls JK, Mantell LL, Cook JL, Alam J, Choi AM. Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J Clin Invest. 1999;103(7):1047-1054.
30. Ferris CD, Jaffrey SR, Sawa A, et al. Heme oxygenase-1 prevents cell death by regulating cellular iron. Nat Cell Biol. 1999;1(3):152-157.
31. Kranjec I. Atherosclerotic burden in coronary and peripheral arteries in patients with frst clinical manifestation of coronary artery disease. J Cardiovasc Med. 2011;12(4):297-299.
32. Simon A, Megnien JL, Chironi G. The value of carotid intima-media thickness for predicting cardiovascular risk. Arterioscler Thromb Vasc Biol. 2010;30(2):182-185.
33. Wald DS, Bestwick J P. Carotid ultrasound screening for coronary heart disease: results based on a meta-analysis of 18 studies and 44, 861 subjects. J Med Screen. 2009;16(3):147-154.
34. Belcaro G, Nicolaides AN, Laurora G, et al. Ultrasound morphology classifcation of the arterial wall and cardiovascular events in a 6-year follow-up study. Arterioscler Thromb Vasc Biol. 1996;16(7):851-856.
35. Morito N, Inoue Y, Urata M, et al. Increased carotid artery plaque score is an independent predictor of the presence and severity of coronary artery disease. J Cardiol. 2008;51(1):25-32.
36. Inaba Y, Chen JA, Bergmann SR. Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis. Atheroscleroris. 2012;220(1):128-133.
37. Seo Y, Watanabe D, Ishizu T, et al. Echolucent carotid plaques as a feature in patients with acute coronary syndrome. Circ J. 2006;70(12):1629-1634.
38. Nicholls SJ, Hsu A, Wolski K, et al. Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome. J Am Coll Cardiol. 2010;55(21):2399-2407.
39. Van Craeyveld E, Gordts SG, Nefyodova E, Jacobs F, De Geest B. Regression and stabilization of advanced murine atherosclerotic lesions: a comparison of LDL lowering and HDL raising gene transfer strategies. J Mol Med. 2011;89(6):555-567.
40. Walldius G, Jungner I. Apolipoprotein A-1 versus HDL cholesterol in the prediction of risk for myocardial infarction and stroke. Curr Opin Cardiol. 2007;22(4):359-367.
41. Rodriguez-Granillo GA, Garcia-Garcia HM, McFadden E P, et al. In vivo intravascular ultrasound-derived thin-cap fbroatheroma detection using ultrasound radiofrequen-cy data analysis. J Am Coll Cardiol. 2005;46(11):2038-2042.
42. Marso S P, Frutkin AD, Mehta SK, et al. Intravascular ultrasound measures of coronary atherosclerosis are associated with the Framingham risk score: an analysis from a global IVUS registry. EuroIntervention. 2009;5(2):212-218.
43. Abdel-Wahab M, Khattab AA, Liska B, et al. Relationship between cardiovascular risk as predicted by established risk scores and coronary artery plaque composition as detected by virtual histology intravascular ultrasound analysis. The PREDICT pilot study. EuroIntervention. 2008;3(4):482-489.
44. Serruys PW, Garcia-Garcia HM, Buszman P, et al. Effects of the direct lipoprotein-associated phospholipase A2 inhibitor darapladib on human coronary atherosclerosis plaque. Circulation. 2008;118(11):1172-1182.
45. Kovarnik T, Mintz GS, Skalicka H, et al. Virtual histology evaluation of atherosclerosis regression during atorvastatin and ezetimibe administration - HEAVEN study. Circ J. 2012;76(1):176-183.
46. Hong MH, Mintz GS, Lee C W, et al. A three-vessel virtual histology intravascular ultrasound analysis of frequency and distribution of thin-cap fbroatheromas in patients with acute coronary syndromes or stable angina pectoris. Am J Cardiol. 2008;101(5):568-572.